HCV E2 glycoprotein binding e-137 (Fides Pharma)

N/A

Report date: 2025/01/26 16:23:00

Base Information

Drug NameHCV E2 glycoprotein binding e-137 (Fides Pharma)
Drug Alias Namee-137 (Pomona)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionHepatitis C virus E2 glycoprotein modulators
TargetsHepatitis C virus E2 glycoprotein
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPomona Ricerca Srl
China Registration ClassN/A

Develop Information

Active CompaniesFides Pharma Spa
Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A